The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine Post author:Sam Post published:August 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Tiny OncoSec Surges on Promising Phase II Melanoma Data November 7, 2017 DaVita Clinical Research Launches Alliance Site Network For Early Stage CKD Trials June 14, 2017 Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017
Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017